MedTrace Logo

Clinical Trial of Chemosensitivity Test

NCT00287755 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2011-06-29

No results posted yet for this study

Summary

To evaluate the usefulness of chemosensitivity test in evaluating the appropriate adjuvant cancer chemotherapy after gastric surgery

Conditions

Interventions

DRUG

S-1

S-1 capsule at a dose of 80 mg/m2 b.i.d. for 4 weeks followed by 2 weeks rest.

Sponsors & Collaborators

  • Kitasato University

    collaborator OTHER

  • Japan Clinical Cancer Research Organization

    lead OTHER

Principal Investigators

  • Tetsuro Kubota, Processor · Keio University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2010-12-31
Completion
2011-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287755 on ClinicalTrials.gov